Efficacy and Safety of EGT0001442 Compared With Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Diet and Exercise and up to One Oral Anti-diabetes Agent
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2016
At a glance
- Drugs Bexagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Theracos
- 10 Jun 2017 Biomarkers information updated
- 28 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Dec 2011 Actual initiation date changed from Jun 2011 to Dec 2011 as reported by ClinicalTrials.gov.